AD patients had reduced brain insulin receptor (IR) activity, lower CSF insulin levels and peripheral blood hyperinsulinemia [85,118] and an attenuated expression of IR and IGF receptors [119]. The gene discussed is INS; the disease is Alzheimer disease.